0000874015-12-000045.txt : 20120703 0000874015-12-000045.hdr.sgml : 20120703 20120703190937 ACCESSION NUMBER: 0000874015-12-000045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120702 FILED AS OF DATE: 20120703 DATE AS OF CHANGE: 20120703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLEIN JOSEPH III CENTRAL INDEX KEY: 0001206369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 12946630 MAIL ADDRESS: STREET 1: C/O GENAISSANCE PHARMACEUTICALS INC STREET 2: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2012-07-02 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001206369 KLEIN JOSEPH III C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 0 0 0 Restricted Stock Units 2012-07-02 2012-07-02 4 A 0 1250 0 A Common Stock 1250 1250 D Director Stock Option (right to buy) 12.94 2012-07-02 2012-07-02 4 A 0 11250 0 A 2013-07-02 2022-07-01 Common Stock 11250 11250 D Each restricted stock unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value. The restricted stock units vest in four equal annual installments, the first installment vesting on July 2, 2013. Upon vesting, the restricted stock units will be paid out in whole shares of Isis common stock or cash as may be determined by the Company. The RSU shall be fully vested on July 2, 2016. The RSU is vested as to 0 shares on July 2, 2012. Grant of 7-2-12 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 2002 Non Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on 7-2-13. The option shall be fully vested and exercisable on 7/2/2016. The option is exercisable as to 0 shares on 7/2/2012. /s/B. Lynne Parshall, Attorney-in-Fact 2012-07-03